Q-Bank Breakdown: P-value interpretation — Why Every Answer Choice Matters

Biostatistics questions love to weaponize one simple fact: a P-value does not tell you the probability that the null hypothesis is true. On test day, that misunderstanding turns into easy trap answers—especially when the stem uses confident language like “proved,” “no difference,” or “clinically significant.” Let’s walk through a classic clinical vignette and then do what actually boosts your score: interrogate every answer choice.

💡

Tag: Biostatistics > Study Design & Probability

---

The Vignette (Q-bank style)

A randomized controlled trial compares a new anticoagulant (Drug A) with standard therapy (Drug B) for prevention of recurrent DVT. After 6 months, recurrent DVT occurred in 8% of patients on Drug A and 12% on Drug B. The study reports a P-value of 0.03 for the difference in recurrence rates.

Which statement best interprets this P-value?

A. There is a 3% chance the null hypothesis is true.
B. There is a 3% chance that the observed difference (or a more extreme one) would occur if there were truly no difference between drugs.
C. Drug A reduces DVT recurrence by 3%.
D. The probability that Drug A is better than Drug B is 97%.
E. Because $P < 0.05$, the difference is clinically significant.

---

Step 1: Identify the Null and What the P-value Refers To

• Null hypothesis ($H_0$): no true difference in DVT recurrence between Drug A and Drug B in the population (e.g., risk difference $= 0$).
• P-value definition: the probability of getting the observed result or something more extreme, assuming $H_0$ is true.

That assumption clause is everything.

---

Correct Answer: B

💡

B. There is a 3% chance that the observed difference (or a more extreme one) would occur if there were truly no difference between drugs.

This is the standard interpretation:

• $P = 0.03$ means: If there is truly no difference between Drug A and Drug B (null is true), then there is a 3% probability of observing a difference at least as large as what this study saw, due to random sampling variability.

High-yield phrasing to memorize

• “Probability of data (or more extreme data) given the null”
  $P = P(\text{data} \mid H_0)$
• Not: $P(H_0 \mid \text{data})$ (that’s a different framework, i.e., Bayesian).

---

Now, Let’s Kill the Distractors (Where Points Are Made)

A. “There is a 3% chance the null hypothesis is true.” ❌

Classic trap.

• The P-value does not give $P(H_0 \text{ is true})$.
• In frequentist testing, $H_0$ is treated as fixed (true or false), and randomness comes from sampling.

Why it’s tempting: feels intuitive (“small P means null unlikely”).
Why it’s wrong: it flips the conditional probability.

---

C. “Drug A reduces DVT recurrence by 3%.” ❌

This confuses the P-value with the effect size.

From the stem:

• Recurrence is 8% vs 12%
• Absolute risk reduction (ARR) = $12\% - 8\% = 4\%$

So even if they were asking effect size:

• It would be 4%, not 3%.

High-yield distinction

• P-value: evidence against $H_0$ (statistical compatibility)
• Effect size: magnitude of difference (ARR, RR, OR, mean difference)

---

D. “The probability that Drug A is better than Drug B is 97%.” ❌

Another conditional probability trap.

• A P-value is not the probability the alternative hypothesis is true.
• “Probability Drug A is better” is closer to Bayesian posterior probability, not what standard hypothesis testing reports.

USMLE test-writer move: they’ll use “97%” because $1 - 0.03 = 0.97$, hoping you take the bait.

---

E. “Because $P < 0.05$, the difference is clinically significant.” ❌

Statistical significance ≠ clinical significance.

• A tiny effect can be statistically significant with a large sample size.
• A clinically meaningful effect can fail to reach statistical significance if the study is underpowered.

Clinical significance depends on:

• the effect size (e.g., ARR)
• patient-centered outcomes
• harms/costs
• baseline risk and context

Quick plug-in from the stem:

• ARR = 4% → NNT $= \frac{1}{0.04} = 25$ (over 6 months)
• Whether an NNT of 25 is “clinically significant” depends on bleeding risk, cost, and severity of outcome—not on $P < 0.05$ alone.

---

High-Yield P-value Facts (USMLE-Friendly)

What a P-value is

• Probability of observing the study result (or more extreme) if $H_0$ is true
• Measures statistical incompatibility between data and $H_0$

What a P-value is not

• Not the probability the null is true
• Not the probability results occurred “by chance” in a colloquial sense
• Not a measure of effect size
• Not proof of clinical importance

Common thresholds (convention, not law)

• Often compare to $\alpha = 0.05$ (Type I error rate)
• If $P < \alpha$, call it “statistically significant” → reject $H_0$

---

Quick Table: P-value vs $\alpha$ vs Errors (Test Day Clarifier)

---

How This Shows Up on Step 1 vs Step 2

Step 1 emphasis

• Correct interpretation of P-values
• Type I/II errors, $\alpha$, $\beta$, power
• Avoiding conditional probability reversals

Step 2 emphasis

• Applying meaning clinically:
  • “Statistically significant” doesn’t automatically change practice
  • Consider effect size (NNT/NNH), confidence intervals, external validity
• Recognizing when authors overclaim based on P-values alone

---

The “Every Answer Choice Matters” Takeaway

When you see a P-value question, train your brain to ask:

1. What is $H_0$?
2. Is this statement describing $P(\text{data}\mid H_0)$ (correct) or $P(H_0\mid \text{data})$ (wrong)?
3. Is the choice mixing up P-value with effect size, confidence interval, or clinical significance?

If you do those three checks, you’ll catch nearly every trap.